PsyBio Therapeutics Corp. (PSYBF) Research

Headquartered in Coconut Creek, Florida, PsyBio Therapeutics Corp. is a biotechnology firm dedicated to the discovery, development, and market launch of regulated, psychedelic-derived medications. These innovative treatments are intended for addressing mental health challenges and various other conditions throughout the United States.

Market snapshot

Symbol
PSYBF
Price
$0.00
Day change
0.00%
Market cap
$1.3K
P/E ratio
-0.00x
52-week range
0.00001-0.005
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Arch Biopartners Inc. (ACHFF)
  • CVR Medical Corp. (CRRVF)
  • Covalon Technologies Ltd. (CVALF)
  • Elixxer Ltd. (ELIXF)
  • Helix BioPharma Corp. (HBPCF)
  • Amplia Therapeutics Limited (INNMF)
  • Oncotelic Therapeutics, Inc. (OTLC)
  • MindMaze Therapeutics Holding S.A. (RLFTF)

Open PsyBio Therapeutics Corp. (PSYBF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.